罗哌卡因复合舒芬太尼用于肺癌患者术后镇痛的临床观察

目的 评估罗哌卡因复合不同浓度舒芬太尼用于肺癌手术后硬膜外镇痛(PCEA)效果及不良反应.方法 选取择期肺癌行肺叶切除术患者90例,年龄20～67岁,随机分成3组,每组30例,术前T 6-7行硬膜外穿刺,留置导管,术后接硬膜外镇痛泵.分别用罗哌卡因复合舒芬太尼0.1 μg/ml(Ⅰ组)、0.2μg/ml(Ⅱ组)和0....

Post-operative Epidurai Analgesia with Ropivacaine Combined Sufentanil Patients Undergone Lung Cancer Surgery

ObjectiveTo evaluate the clinical outcomes of postoperative epidural analgesia with Ropivacaine combined with sufentanil in patients undergone lung cancer surgery.MethodsNinety patients aged from 20 to 66 years old undergone lung cancer were randomized into three groups,with 30 cases each group.Patientcontrolled epidural analgesia（PCEA）was used with Ropivacaine 0.15% plus sufentanil 0.1 μg/ml in group Ⅰ,plus sufentanil 0.2 μg/ml in group Ⅱ,or plus sufentanil 0.3 μg/ml in group Ⅲ,Visual analog scale（VAS）pain scores at calm condition and during coughing were evaluated and side effects were recorded during analgesia.ResultsIn 2,4,8h after operation,VASscores at calm ciydution and during coughing of group Ⅱ and Ⅲwere less than that of guoup Ⅰ（P0.05）.ConclusionPCEA with 0.15% Ropivacaine combined 0.1,0.2 or 0.3 μg/ml provides a satisfactory analgesic efficacy in patients undergone lung cancer surgery.Ropivacaine 0.15% combined with Sufentanyl 0.2 μg/ml is preferable recommendation with lower incidence of adverse events.